REPRESSION OF HBS IN SICKLE CELL ANEMIA

镰状细胞性贫血中 HBS 的抑制

• 批准号: 2854174
• 负责人: Patricia E Berg
• 金额: $ 2.2万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-08-01 至 1998-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2854174
• 关键词: REPRESSION; HBS; SICKLE; CELL; ANEMIA

DESCRIPTION (Adapted from Applicant's Abstract): The goal of these studies is to examine the molecular properties of three genes we have cloned, BP1, BP2, and HMG-1(Y), which data from our laboratory and others suggest are repressors of the b-globin gene. Data presented in this proposal points to the potential importance of BP1 in hematopoiesis: the expression of BP1 is restricted to hematopoietic cells after birth, and sequencing has revealed that BP1 contains a homeobox gene, placing it in a class of genes central to development. BP2 is ubiquitously expressed, suggesting a more general role in globin regulation. The investigators have also cloned a CDNA encodng HMG-1(Y), a known protein which we demonstrate binds to and bends Silencer 1 DNA, making it a strong candidate for involvement in repression of the b-globin gene. They will define the role(s) of BP1, BP2 and HMG-1(Y) in normal erythroid development and determine their potential to ameliorate the complications seen in sickle cell anemia (SCA). Benefits of reduction of bs globin expression by repressors may be indirect, since repression of b-globin may lead to reciprocal activation of g -globin. In addition repression of the endogenous bs globin gene would reduce the amount of HbS, favoring the formation of Hb F or Hb A after introduction of a normal g -globin gene or b-globin gene, respectively. BP1 and/or BP2 may directly activate g -globin gene expression, as well: both transcription factors bind upstream of g -globin genes, and there is a direct correlation of reactivation of fetal genes and increased binding activity of BP1 in patients. The ability of these genes to repress b-globin will be measured in cultured cells and in erythroid progenitors grown in a liquid culture system. Expression of BP1, BP2 and HMG-1(Y) will be decreased in erythroid progenitors from cord blood to determine whether this will cause a switch from fetal to adult hemoglobin synthesis. To further examine the functions of BP1 and BP2, transgenic mice will be created overexpressing BP1 and BP2 in their erythroid cells. The proposed studies will firmly establish the role of cloned BP1, BP2 and HMG-1(Y) CDNAS in the repression of the b-globin gene and will determine whether these genes may be useful in the therapy of sickle cell anemia.

描述（改编自申请人摘要）：这些研究的目标 是检验我们克隆的三个基因的分子特性，BP 1， BP 2和HMG-1（Y），我们实验室和其他实验室的数据表明， b-珠蛋白基因的阻遏物。 本提案中提供的数据表明， BP 1在造血中的潜在重要性： 仅限于出生后的造血细胞，测序显示 BP 1包含一个同源框基因，将其置于一类基因的核心， 发展 BP 2普遍表达，表明其在细胞内的作用更普遍。 在珠蛋白调节中。 研究人员还克隆了一个编码 HMG-1（Y）是一种已知的蛋白质，我们证明它与沉默蛋白1结合并使其弯曲 DNA，使其成为参与镇压的强有力的候选人， b-珠蛋白基因。 它们将确定BP 1、BP 2和HMG-1（Y）在以下方面的作用： 正常的红细胞发育，并确定其改善红细胞发育的潜力。 镰状细胞性贫血（SCA）的并发症。 减少BS的好处 球蛋白表达的阻遏物可能是间接的，因为阻遏球蛋白的表达可能是间接的。 β-珠蛋白可导致β-珠蛋白的相互激活。 此外 内源性bs珠蛋白基因的抑制将减少HbS的量， 在引入正常g后，有利于形成Hb F或Hb A - 珠蛋白基因或b-珠蛋白基因。 BP 1和/或BP 2可以直接 激活G -珠蛋白基因的表达，以及：这两个转录因子 结合在G -珠蛋白基因的上游， 胎儿基因的重新激活和BP 1结合活性的增加， 患者 将测量这些基因抑制b-珠蛋白的能力 在培养的细胞和在液体培养物中生长的红系祖细胞中 系统 BP 1、BP 2和HMG-1（Y）在红系细胞中的表达降低 以确定这是否会导致转换 从胎儿到成人血红蛋白的合成。 为了进一步研究 BP 1和BP 2的转基因小鼠将被创建为过表达BP 1和BP 2 在他们的红细胞中。 拟议的研究将坚定地建立 克隆的BP 1、BP 2和HMG-1（Y）CDNAS在抑制b-珠蛋白中的作用 基因，并将确定这些基因是否可用于治疗 镰状细胞性贫血